DOCSLIB.ORG

2020 Epi Case Criteria Guide

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
2020 Epi Case Criteria Guide TEXAS DEPARTMENT OF STATE HEALTH SERVICES Infectious Disease Control Unit Epi Case Criteria Guide, 2020 Revision date: January 2020 Texas Department of State Health Services Epi Case Criteria Guide, 2020 Editor Laura Tabony, MPH Contributors Adam Lynch, MPH Johnathan Ledbetter, MPH Adrienne Fung, MPH Jonathan Kolsin, MPH Anna Nutt, MPH, CIC Kamesha Owens, MPH Bonny Mayes, MA Kelly Broussard, MPH Briana O’Sullivan, MPH Laura Robinson, DVM, MS Carlos R. Alvarez, MPH, CPH, A-IPC Melba Zambrano, MSN, RN, CIC Eric Garza, MPH Rachael Straver, DVM, MPH Gillian Blackwell, BSN, RN, CIC Sandi Arnold, RN, CIC Greg Leos, MPH, CPH Sepehr Arshadmansab, MPH Irina Cody, MPH Thi Dang, MPH, CIC Texas Department of State Health Services Infectious Disease Control Unit Emerging and Acute Infectious Disease Branch//Zoonosis Control Branch Mail Code 1960 PO Box 149347 Austin, TX 78714-9347 Phone 512.776.7676 • Fax 512.776.7616 Revised: January-October 2020 Publication No. E59-11841 Revision date: January – October 2020 ~ ii REVISIONS MADE FROM THE 2019 TO THE 2020 EPI CASE CRITERIA GUIDE Changes in scope/name . Anaplasma phagocytophilum infection to Anaplasmosis . Ehrlichia chaffeensis infection to Ehrlichiosis (Ehrlichia chaffeensis infection) . Ehrlichia ewingii infection to Ehrlichiosis (Ehrlichia ewingii infection) . Novel coronavirus to Novel Coronavirus 2019 . Spotted fever group rickettsioses to Spotted fever rickettsiosis Revisions of case criteria for Clinical Description and/or criteria (CD); Confirmed, Probable, Possible, or Suspect cases (CC, PC, PsC, SC); Laboratory Confirmation tests (LC); and Note(s) (N) . Acute flaccid myelitis ........................................................CD, CC, PC, SC, LC . Mumps ................................................................................................................ SC . Anaplasmosis ............................................................................................ CD, LC . Novel coronavirus 2019 .................................................. CD, CC, PC, SC, LC, N . Ascariasis .......................................................................................... CD, PC, LC . Pertussis .........................................................................................................CD, N . Carbapenem-resistant Enterobacteriaceae (CRE)..................................... CD, N . Plague ............................................................................. CD, LC, CC, PC, SC, N . Chagas disease, acute .................................................................................. PC, N . Prion diseases such as Creutzfeldt-Jakob disease (CJD) ... CD, CC, PC, PsC, N . Chagas disease, chronic indeterminate ....................................... CC, PC, SC, N . Q fever, acute ...................................................................................... CD, LC, PC . Chagas disease, chronic symptomatic ........................................ CC, PC, SC, N . Rickettsiosis, unspecified ..................................................................... CD, PC, N . Ehrlichiosis (Ehrlichia chaffeensis infection) ............................. CD, PC, LC . Typhus ........................................................................................... CD, PC, LC, N . Ehrlichiosis (Ehrlichia ewingii infection) ................................................... CD . Spotted fever group rickettsioses .......................................................... LC, PC, N . Ehrlichiosis/Anaplasmosis undetermined .................................................. CD . Trichuriasis ................................................................................................. CD, LC . Ebola (HF) ................................................................................... CD, SC, LC, N . Typhus, flea-borne (endemic, murine) ................................................ CD, LC, N . Fascioliasis ........................................................................................................ LC . Viral hemorrhagic fever (VHF) Non-Ebola ............................................ CD, SC . Hookworm (ancylostomiasis) ................................................................. CD, LC . Yersiniosis ...................................................................................... CD, PC, LC, N . Legionellosis ..................................................................................... CD, PC, LC . Multidrug-resistant Acinetobacter (MDR-A) .......................................... CD, N Revision date: January – October 2020 ~ iii ~ TABLE OF CONTENTS This document provides infectious disease information for surveillance and data entry staff. It contains a table with condition codes, condition names, and case criteria to aid in the classification and coding of conditions. It is organized alphabetically by condition name. Conditions specified as reportable in Title 25, Texas Administrative Code, Chapter 97, Subchapter A, Control of Communicable Diseases are in bold type. Click on a condition in the table of contents to go to the text and on the condition code to move back. Editor .............................................................................................................................................................................................................................................. ii Contributors ................................................................................................................................................................................................................................. ii REVISIONS MADE FROM THE 2019 TO THE 2020 EPI CASE CRITERIA GUIDE ......................................................... ii Table of Contents ........................................................................................................................................................................... iv Definition of Terms ....................................................................................................................................................................... vii Abbreviations ................................................................................................................................................................................ viii Notes ................................................................................................................................................................................................ ix CASE CRITERIA ............................................................................................................................................................................... 10 Acute Flaccid Myelitis ..................................................................................................................................................................................................................................................................................... 10 Amebiasis .............................................................................................................................................................................................................................................................................................................. 10 Am Amebic meningitis/encephalitis, other................................................................................................................................................................................................................................................ 11 Amebic meningoencephalitis, primary (PAM) ............................................................................................................................................................................................................................. 12 Anaplasmosis (Anaplasma phagocytophilum infection) ........................................................................................................................................................................................................ 12 Anthrax .................................................................................................................................................................................................................................................................................................................. 13 Arbovirus, neuroinvasive (encephalitis/meningitis) and non-neuroinvasive ............................................................................................................................................................. 14 Ascariasis .............................................................................................................................................................................................................................................................................................................. 15 Ba Babesiosis .............................................................................................................................................................................................................................................................................................................. 16 Botulism, foodborne......................................................................................................................................................................................................................................................................................
Load more

Recommended publications
  • Official Nh Dhhs Health Alert
    THIS IS AN OFFICIAL NH DHHS HEALTH ALERT Distributed by the NH Health Alert Network [email protected] May 18, 2018, 1300 EDT (1:00 PM EDT) NH-HAN 20180518 Tickborne Diseases in New Hampshire Key Points and Recommendations: 1. Blacklegged ticks transmit at least five different infections in New Hampshire (NH): Lyme disease, Anaplasma, Babesia, Powassan virus, and Borrelia miyamotoi. 2. NH has one of the highest rates of Lyme disease in the nation, and 50-60% of blacklegged ticks sampled from across NH have been found to be infected with Borrelia burgdorferi, the bacterium that causes Lyme disease. 3. NH has experienced a significant increase in human cases of anaplasmosis, with cases more than doubling from 2016 to 2017. The reason for the increase is unknown at this time. 4. The number of new cases of babesiosis also increased in 2017; because Babesia can be transmitted through blood transfusions in addition to tick bites, providers should ask patients with suspected babesiosis whether they have donated blood or received a blood transfusion. 5. Powassan is a newer tickborne disease which has been identified in three NH residents during past seasons in 2013, 2016 and 2017. While uncommon, Powassan can cause a debilitating neurological illness, so providers should maintain an index of suspicion for patients presenting with an unexplained meningoencephalitis. 6. Borrelia miyamotoi infection usually presents with a nonspecific febrile illness similar to other tickborne diseases like anaplasmosis, and has recently been identified in one NH resident. Tests for Lyme disease do not reliably detect Borrelia miyamotoi, so providers should consider specific testing for Borrelia miyamotoi (see Attachment 1) and other pathogens if testing for Lyme disease is negative but a tickborne disease is still suspected.
    [Show full text]
  • ABSTRACT DRAKE, STEPHENIE LYNN. the Ecology Vibrio
    ABSTRACT DRAKE, STEPHENIE LYNN. The Ecology Vibrio vulnificus and Vibrio parahaemolyticus from Oyster Harvest Sites in the Gulf of Mexico. (Under the direction of Dr. Lee-Ann Jaykus). The Vibrionaceae are environmentally ubiquitous to estuarine waters. Two species in particular, V. vulnificus and V. parahaemolyticus, are important human pathogens that are transmitted by the consumption of contaminated molluscan shellfish. There is limited information available for the recent risk assessments; accordingly, the purpose of this study was to address some of these data gaps in the V. vulnificus and V. parahaemolyticus risk assessments. The objectives of this study were to (i) quantify the levels of total estuarine bacteria, total Vibrio spp., and specific levels of non-pathogenic and pathogenic V. vulnificus and V. parahaemolyticus over the harvest period; and (ii) determine if length of harvest time affects the levels of V. vulnificus. Oyster and water samples were harvested seasonally from 3 U.S. Gulf Coast sites over 2 years. Environmental parameters were monitored during harvesting. Both surface and bottom water samples (1 L) were taken at the beginning of harvesting and at the end of harvesting. Oyster samples (15 specimens for each time point) were taken at 0, 2.5, 5.0, 7.5, and 10 hrs intervals after being held at ambient temperature during harvesting. Samples were processed for many different bacteria. For enumeration of total V. parahaemolyticus, pathogenic V. parahaemolyticus, and V. vulnificus was done using colony lift hybridization (tlh, tdh+ and/or trh+, and vvhA gene targets, respectively). MPN methods were also used to obtain estimates of pathogenic V.
    [Show full text]
  • Recognizing and Treating New and Emerging Infections Encountered in Everyday Practice
    Recognizing and treating new and emerging infections encountered in everyday practice STEVEN M. GORDON, MD NFECTIOUS DISEASES, pre- MiikWirj:« Although infectious diseases were once considered a dicted earlier in this cen- diminishing threat, new pathogens are constantly challenging tury to be eliminated as a the health care system. This article reviews the clinical presen- public health problem, re- tation, diagnosis, and treatment of seven emerging infections I main the chief cause of death that primary care physicians are likely to encounter. worldwide and a significant cause of death and morbidity in i Parvovirus B19 attacks erythrocyte precursors; the United States.1 Challenging infection is usually benign and self-limiting but can cause the US public health system are aplastic crises in patients with chronic hemolytic disorders. several newly identified patho- Hemorrhagic colitis due to Escherichia coli 0157:H7 infection gens (eg, human immunodefi- can lead to the hemolytic-uremic syndrome, especially in chil- ciency virus [HIV], Escherichia dren; it also can cause thrombotic thrombocytopenia purpura. coli 0157:H7, hepatitis C) and a Chlamydia pneumoniae causes a mild pneumonia that resem- resurgence of old diseases pre- bles mycoplasmal pneumonia. Bacillary angiomatosis primar- sumed to be under control (eg, ily affects immunocompromised patients, especially those tuberculosis, syphilis). Further, infected with human immunodeficiency virus (HIV). At least multiple-drug resistance in two organisms can cause bacillary angiomatosis: Bartonella hense- strains of pneumococci, gono- lae and Bartonella quintana. Hantavirus pulmonary syndrome cocci, enterococci, staphylo- is spread by exposure to the droppings of infected rodents. cocci, salmonella, and mycobac- Contrary to previous thought, HIV continues to replicate teria undermines efforts to throughout the course of the illness and does not have a latency control the diseases they cause.2 phase.
    [Show full text]
  • Naeglaria and Brain Infections
    Can bacteria shrink tumors? Cancer Therapy: The Microbial Approach n this age of advanced injected live Streptococcus medical science and into cancer patients but after I technology, we still the recipients unfortunately continue to hunt for died from subsequent innovative cancer therapies infections, Coley decided to that prove effective and safe. use heat killed bacteria. He Treatments that successfully made a mixture of two heat- eradicate tumors while at the killed bacterial species, By Alan Barajas same time cause as little Streptococcus pyogenes and damage as possible to normal Serratia marcescens. This Alani Barajas is a Research and tissue are the ultimate goal, concoction was termed Development Technician at Hardy but are also not easy to find. “Coley’s toxins.” Bacteria Diagnostics. She earned her bachelor's degree in Microbiology at were either injected into Cal Poly, San Luis Obispo. The use of microorganisms in tumors or into the cancer therapy is not a new bloodstream. During her studies at Cal Poly, much idea but it is currently a of her time was spent as part of the undergraduate research team for the buzzing topic in cancer Cal Poly Dairy Products Technology therapy research. Center studying spore-forming bacteria in dairy products. In the late 1800s, German Currently she is working on new physicians W. Busch and F. chromogenic media formulations for Fehleisen both individually Hardy Diagnostics, both in the observed that certain cancers prepared and powdered forms. began to regress when patients acquired accidental erysipelas (cellulitis) caused by Streptococcus pyogenes. William Coley was the first to use New York surgeon William bacterial injections to treat cancer www.HardyDiagnostics.com patients.
    [Show full text]
  • Kellie ID Emergencies.Pptx
    4/24/11 ID Alert! recognizing rapidly fatal infections Susan M. Kellie, MD, MPH Professor of Medicine Division of Infectious Diseases, UNMSOM Hospital Epidemiologist UNMHSC and NMVAHCS Fever and…. Rash and altered mental status Rash Muscle pain Lymphadenopathy Hypotension Shortness of breath Recent travel Abdominal pain and diarrhea Case 1. The cross-country trucker A 30 year-old trucker driving from Oklahoma to California is hospitalized in Deming with fever and headache He is treated with broad-spectrum antibiotics, but deteriorates with obtundation, low platelet count, and a centrifugal petechial rash and is transferred to UNMH 1 4/24/11 What is your diagnosis? What is the differential diagnosis of fever and headache with petechial rash? (in the US) Tickborne rickettsioses ◦ RMSF Bacteria ◦ Neisseria meningitidis Key diagnosis in this case: “doxycycline deficiency” Key vector-borne rickettsioses treated with doxycycline: RMSF-case-fatality 5-10% ◦ Fever, nausea, vomiting, myalgia, anorexia and headache ◦ Maculopapular rash progresses to petechial after 2-4 days of fever ◦ Occasionally without rash Human granulocytotropic anaplasmosis (HGA): case-fatality<1% Human monocytotropic ehrlichiosis (HME): case fatality 2-3% 2 4/24/11 Lab clues in rickettsioses The total white blood cell (WBC) count is typicallynormal in patients with RMSF, but increased numbers of immature bands are generally observed. Thrombocytopenia, mild elevations in hepatic transaminases, and hyponatremia might be observed with RMSF whereas leukopenia
    [Show full text]
  • Morbidity and Mortality Weekly Report Weekly March 20, 2009 / Vol
    Morbidity and Mortality Weekly Report www.cdc.gov/mmwr Weekly March 20, 2009 / Vol. 58 / No. 10 Trends in Tuberculosis — World TB Day — March 24, 2009 United States, 2008 World TB Day is observed each year on March 24 to commemorate the date in 1882 when Dr. Robert Koch In 2008, a total of 12,898 incident tuberculosis (TB) cases announced the discovery of Mycobacterium tuberculosis, the were reported in the United States; the TB rate declined 3.8% bacterium that causes tuberculosis (TB). Worldwide, TB from 2007 to 4.2 cases per 100,000 population, the lowest remains one of the leading causes of death from infectious rate recorded since national reporting began in 1953. This disease. An estimated 2 billion persons are infected with report summarizes provisional 2008 data from the National M. tuberculosis (1). In 2006, approximately 9.2 million TB Surveillance System and describes trends since 1993. persons became ill from TB, and 1.7 million died from Despite this overall improvement, progress has slowed in the disease (1). World TB Day provides an opportunity recent years; the average annual percentage decline in the TB for TB programs, nongovernmental organizations, and rate decreased from 7.3% per year during 1993–2000 to 3.8% other partners to describe problems and solutions related during 2000–2008.* Foreign-born persons and racial/ethnic to the TB pandemic and to support worldwide TB minorities continued to bear a disproportionate burden of TB control efforts. The U.S. theme for this year’s observance disease in the United States. In 2008, the TB rate in foreign- is Partnerships for TB Elimination.
    [Show full text]
  • Diagnostic Code Descriptions (ICD9)
    INFECTIONS AND PARASITIC DISEASES INTESTINAL AND INFECTIOUS DISEASES (001 – 009.3) 001 CHOLERA 001.0 DUE TO VIBRIO CHOLERAE 001.1 DUE TO VIBRIO CHOLERAE EL TOR 001.9 UNSPECIFIED 002 TYPHOID AND PARATYPHOID FEVERS 002.0 TYPHOID FEVER 002.1 PARATYPHOID FEVER 'A' 002.2 PARATYPHOID FEVER 'B' 002.3 PARATYPHOID FEVER 'C' 002.9 PARATYPHOID FEVER, UNSPECIFIED 003 OTHER SALMONELLA INFECTIONS 003.0 SALMONELLA GASTROENTERITIS 003.1 SALMONELLA SEPTICAEMIA 003.2 LOCALIZED SALMONELLA INFECTIONS 003.8 OTHER 003.9 UNSPECIFIED 004 SHIGELLOSIS 004.0 SHIGELLA DYSENTERIAE 004.1 SHIGELLA FLEXNERI 004.2 SHIGELLA BOYDII 004.3 SHIGELLA SONNEI 004.8 OTHER 004.9 UNSPECIFIED 005 OTHER FOOD POISONING (BACTERIAL) 005.0 STAPHYLOCOCCAL FOOD POISONING 005.1 BOTULISM 005.2 FOOD POISONING DUE TO CLOSTRIDIUM PERFRINGENS (CL.WELCHII) 005.3 FOOD POISONING DUE TO OTHER CLOSTRIDIA 005.4 FOOD POISONING DUE TO VIBRIO PARAHAEMOLYTICUS 005.8 OTHER BACTERIAL FOOD POISONING 005.9 FOOD POISONING, UNSPECIFIED 006 AMOEBIASIS 006.0 ACUTE AMOEBIC DYSENTERY WITHOUT MENTION OF ABSCESS 006.1 CHRONIC INTESTINAL AMOEBIASIS WITHOUT MENTION OF ABSCESS 006.2 AMOEBIC NONDYSENTERIC COLITIS 006.3 AMOEBIC LIVER ABSCESS 006.4 AMOEBIC LUNG ABSCESS 006.5 AMOEBIC BRAIN ABSCESS 006.6 AMOEBIC SKIN ULCERATION 006.8 AMOEBIC INFECTION OF OTHER SITES 006.9 AMOEBIASIS, UNSPECIFIED 007 OTHER PROTOZOAL INTESTINAL DISEASES 007.0 BALANTIDIASIS 007.1 GIARDIASIS 007.2 COCCIDIOSIS 007.3 INTESTINAL TRICHOMONIASIS 007.8 OTHER PROTOZOAL INTESTINAL DISEASES 007.9 UNSPECIFIED 008 INTESTINAL INFECTIONS DUE TO OTHER ORGANISMS
    [Show full text]
  • Vol. XXV Issue No. 2 June 2004
    Vol. XXV Issue No. 2 June 2004 Report on the Enhanced Surveillance for Chlamydia West Nile Virus - 2003 Summary and in Women - South Carolina, 1998-2002 the Upcoming Season WAYNE A. DUFFUS, MD, PhD LENA M. BRETOUS, MD, MPH Medical Consultant Medical Consultant Extent of Chlamydia Problem Chlamydia remains a significant health threat among In 2003, South Carolina recorded six human cases of women and adolescents. Most estimates predict that 1 in 20 West Nile Virus (WNV). Surveillance numbers for other WNV sexually active woman of childbearing age or 1 in 10 adoles- positives in 2003 include: 282 birds, 54 equine, 3 mosquito cent girls are infected with chlamydia. In fact, 90% of all pools, and 1 alpaca. See table on page reported cases are in individuals less than 24 years of age. three for human case description. INSIDE THIS ISSUE Unfortunately, 60 – 80% of infected women have no symp- Because of the long stretch of toms, and therefore are not aware of their infection and may warm weather in spring and fall, in- Report on the Enhanced not seek health care. fected mosquitoes have a longer win- Surveillance for Chlamydia is the most commonly reported sexually dow to spread the disease in South Chlamydia in Women - South Carolina, transmitted infection among women in the United States (US). Carolina. The first human WNV case 1998 - 2002 The southeast led the nation in chlamydia prevalence in 2002. in South Carolina during 2003 was also Pg. 1 For example, there were 451.1 cases/100,000 persons diag- the first recorded case in the country nosed in the U.S.
    [Show full text]
  • Anaplasmosis: an Emerging Tick-Borne Disease of Importance in Canada
    IDCases 14 (2018) xxx–xxx Contents lists available at ScienceDirect IDCases journal homepage: www.elsevier.com/locate/idcr Case report Anaplasmosis: An emerging tick-borne disease of importance in Canada a, b,c d,e e,f Kelsey Uminski *, Kamran Kadkhoda , Brett L. Houston , Alison Lopez , g,h i c c Lauren J. MacKenzie , Robbin Lindsay , Andrew Walkty , John Embil , d,e Ryan Zarychanski a Rady Faculty of Health Sciences, Max Rady College of Medicine, Department of Internal Medicine, University of Manitoba, Winnipeg, MB, Canada b Cadham Provincial Laboratory, Government of Manitoba, Winnipeg, MB, Canada c Rady Faculty of Health Sciences, Max Rady College of Medicine, Department of Medical Microbiology and Infectious Diseases, University of Manitoba, Winnipeg, MB, Canada d Rady Faculty of Health Sciences, Max Rady College of Medicine, Department of Internal Medicine, Section of Medical Oncology and Hematology, University of Manitoba, Winnipeg, MB, Canada e CancerCare Manitoba, Department of Medical Oncology and Hematology, Winnipeg, MB, Canada f Rady Faculty of Health Sciences, Max Rady College of Medicine, Department of Pediatrics and Child Health, Section of Infectious Diseases, Winnipeg, MB, Canada g Rady Faculty of Health Sciences, Max Rady College of Medicine, Department of Internal Medicine, Section of Infectious Diseases, University of Manitoba, Winnipeg, MB, Canada h Rady Faculty of Health Sciences, Max Rady College of Medicine, Department of Community Health Sciences, University of Manitoba, Winnipeg, MB, Canada i Public Health Agency of Canada, National Microbiology Laboratory, Zoonotic Diseases and Special Pathogens, Winnipeg, MB, Canada A R T I C L E I N F O A B S T R A C T Article history: Human Granulocytic Anaplasmosis (HGA) is an infection caused by the intracellular bacterium Received 11 September 2018 Anaplasma phagocytophilum.
    [Show full text]
  • 2012 Case Definitions Infectious Disease
    Arizona Department of Health Services Case Definitions for Reportable Communicable Morbidities 2012 TABLE OF CONTENTS Definition of Terms Used in Case Classification .......................................................................................................... 6 Definition of Bi-national Case ............................................................................................................................................. 7 ------------------------------------------------------------------------------------------------------- ............................................... 7 AMEBIASIS ............................................................................................................................................................................. 8 ANTHRAX (β) ......................................................................................................................................................................... 9 ASEPTIC MENINGITIS (viral) ......................................................................................................................................... 11 BASIDIOBOLOMYCOSIS ................................................................................................................................................. 12 BOTULISM, FOODBORNE (β) ....................................................................................................................................... 13 BOTULISM, INFANT (β) ...................................................................................................................................................
    [Show full text]
  • Ehrlichiosis and Anaplasmosis Are Tick-Borne Diseases Caused by Obligate Anaplasmosis: Intracellular Bacteria in the Genera Ehrlichia and Anaplasma
    Ehrlichiosis and Importance Ehrlichiosis and anaplasmosis are tick-borne diseases caused by obligate Anaplasmosis: intracellular bacteria in the genera Ehrlichia and Anaplasma. These organisms are widespread in nature; the reservoir hosts include numerous wild animals, as well as Zoonotic Species some domesticated species. For many years, Ehrlichia and Anaplasma species have been known to cause illness in pets and livestock. The consequences of exposure vary Canine Monocytic Ehrlichiosis, from asymptomatic infections to severe, potentially fatal illness. Some organisms Canine Hemorrhagic Fever, have also been recognized as human pathogens since the 1980s and 1990s. Tropical Canine Pancytopenia, Etiology Tracker Dog Disease, Ehrlichiosis and anaplasmosis are caused by members of the genera Ehrlichia Canine Tick Typhus, and Anaplasma, respectively. Both genera contain small, pleomorphic, Gram negative, Nairobi Bleeding Disorder, obligate intracellular organisms, and belong to the family Anaplasmataceae, order Canine Granulocytic Ehrlichiosis, Rickettsiales. They are classified as α-proteobacteria. A number of Ehrlichia and Canine Granulocytic Anaplasmosis, Anaplasma species affect animals. A limited number of these organisms have also Equine Granulocytic Ehrlichiosis, been identified in people. Equine Granulocytic Anaplasmosis, Recent changes in taxonomy can make the nomenclature of the Anaplasmataceae Tick-borne Fever, and their diseases somewhat confusing. At one time, ehrlichiosis was a group of Pasture Fever, diseases caused by organisms that mostly replicated in membrane-bound cytoplasmic Human Monocytic Ehrlichiosis, vacuoles of leukocytes, and belonged to the genus Ehrlichia, tribe Ehrlichieae and Human Granulocytic Anaplasmosis, family Rickettsiaceae. The names of the diseases were often based on the host Human Granulocytic Ehrlichiosis, species, together with type of leukocyte most often infected.
    [Show full text]
  • Anaplasmosis
    Anaplasmosis Definition: Anaplasmosis is an infection caused by the bacterium Anaplasma phagocytophilum. It is most commonly transmitted by the bite of an infected deer tick (Ixodes scapularis). Signs and symptoms: Symptoms of anaplasmosis can range from mild to very severe and may include: fever, headache, muscle pain, malaise, chills, nausea, abdominal pain, cough, and confusion. Severe symptoms may include: difficulty breathing, hemorrhage, renal failure, or neurological problems. It can be fatal if not treated correctly. People who are immunocompromised or elderly are at higher risk for severe disease. Transmission: Anaplasmosis is primarily transmitted to a person through the bite of an infected deer tick; this tick is endemic throughout Maine. Rarely, it can also be transmitted by receiving blood transfusions from an infected donor. Diagnosis: Anaplasmosis is diagnosed by clinical symptoms and laboratory tests. A blood test is necessary for confirmation. Co-infections with other tick-borne diseases may occur and should be considered. Role of the School Nurse: Prevention • Provide education on prevention efforts including: wearing protective clothing, using an EPA- approved repellent, using caution in tick infested areas, and performing daily tick checks. • Encourage the use of EPA approved repellents when outside (following local policy guidelines), and always performing a tick check when returning indoors. o School nurses can apply repellent with parental permission • If a tick is found, the school nurse should remove the tick using tweezers or a tick spoon. o Tick identification cards are available at: http://www.maine.gov/dhhs/mecdc/infectious- disease/epi/vector-borne/posters/index.shtml. o Testing of the tick is not recommended.
    [Show full text]